Frederic Colland

Title: Frederic Colland: Innovator in Ubiquitin Specific Protease Inhibition

Introduction

Frederic Colland is a notable inventor based in Issy-les-Moulineaux, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective inhibitors for ubiquitin specific proteases. His work has the potential to impact therapeutic applications significantly.

Latest Patents

Frederic Colland holds a patent for "Selective inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications." This invention focuses on the discovery of new selective inhibitors of ubiquitin specific proteases, detailing their preparation process and therapeutic uses. He has 1 patent to his name, showcasing his innovative approach to addressing complex biological challenges.

Career Highlights

Colland is associated with Hybrigenics S.A., a company that specializes in biotechnology and pharmaceutical research. His role at Hybrigenics has allowed him to explore and develop groundbreaking solutions in the field of protease inhibition.

Collaborations

Frederic has worked alongside his coworker, Roman Lopez, contributing to the advancement of their shared research goals. Their collaboration emphasizes the importance of teamwork in scientific innovation.

Conclusion

Frederic Colland's work in the field of ubiquitin specific protease inhibitors represents a significant advancement in pharmaceutical research. His innovative contributions continue to pave the way for new therapeutic applications.